Examine the Involvement of Glial cells and Neuroplasticity in Neuro-inflammatory Responses and Neurodegenerative Diseases
Main Article Content
Authors
Abstract
Glial cells, such as microglia, astrocytes, and oligodendrocytes, play a vital function in maintaining the stability of the vital nervous machine (CNS), regulating the activities of synapses, and controlling neuroinflammatory responses. Neurodegenerative illnesses, consisting of Alzheimer's disorder, Parkinson's ailment, and more than one sclerosis, consist of the continuing activation of glial cells, which results in a damaging loop of chronic neuroinflammation and bad neuroplasticity. Microglia, the immune cells that exist in the vital nervous device (CNS), undergo hyperactivation while uncovered to harmful stimuli. This ends in the release of pro-inflammatory cytokines and reactive oxygen species, which in turn result in damage to neurones. Astrocytes, which give structural and metabolic help to neurones, also revel in reactive changes that make contributions to the inflammatory environment and disturb synaptic plasticity, a vital mechanism for learning and reminiscence. Oligodendrocytes, that are critical for the system of myelination in neurones, are also impacted in a comparable way, leading to a lower inside the capacity of neurones to hold electric signals. This research paper examines the molecular and cellular processes that cause glial cell activation and its subsequent effect on neuroplasticity. The objective is to discover new therapeutic methods to regulate glial function, decrease neuro-inflammation, and promote neural repair in neurodegenerative diseases. This work aims to enhance our comprehension of glial cell dynamics and their interaction with neuroplastic processes, with the ultimate goal of facilitating the development of groundbreaking therapies capable of arresting or maybe reversing the advancement of these incapacitating disorders.
Downloads
Article Details
Section
References
- Ahuja, M., & Sharma, P. (2015). Neuroinflammation: The role of cytokines and chemokines in neurodegenerative diseases. Journal of Neuroinflammation, 12(1), 207.
- Banerjee, R., & Nandini, M. (2016). The role of microglial cells in Alzheimer's disease. Indian Journal of Medical Research, 143(4), 434-441.
- Bhattacharya, A., & Sharma, R. (2019). Neuroinflammatory markers in Parkinson's disease. Journal of Parkinson's Disease, 9(2), 341-352.
- Bindu, M. S., & Ramasamy, K. (2018). Astrocytes and neuroinflammation in multiple sclerosis. Journal of the Neurological Sciences, 387, 34-44.
- Bose, S., & Roy, A. (2020). The impact of glial cell activation on neuroplasticity. Frontiers in Cellular Neuroscience, 14, 120.
- Chandra, V., & Pandey, M. (2017). Glial cells and Alzheimer's disease. Indian Journal of Clinical Neurosciences, 24(2), 89-98.
- Das, S., & Banerjee, S. (2018). Role of neuroplasticity in neurodegenerative diseases. Journal of Neuroscience Research, 96(6), 999-1011.
- David, S., & Kroner, A. (2011). Repertoire of microglial and macrophage responses after spinal cord injury. Nature Reviews Neuroscience, 12(7), 388-399.
- Freeman, M. R. (2010). Specification and morphogenesis of astrocytes. Science, 330(6005), 774-778.
- Ghosh, A., & Sarkar, S. (2019). The role of inflammation in neurodegenerative diseases: A focus on Alzheimer's disease. Journal of Neuroinflammation, 16(1), 1-13.
- Gupta, R., & Singh, P. (2020). Modulation of glial cells in neurodegenerative diseases. Journal of Cellular and Molecular Medicine, 24(1), 253-264.
- Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015). Immune attack: the role of inflammation in Alzheimer disease. Nature Reviews Neuroscience, 16(6), 358-372.
- Heneka, M. T., et al. (2015). Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), 388-405.
- Jha, S. K., & Chaturvedi, R. K. (2019). Neuroinflammation and oxidative stress in Alzheimer's disease: Indian perspectives. Indian Journal of Experimental Biology, 57(6), 405-417.
- Kalia, L. V., & Lang, A. E. (2015). Parkinson's disease. The Lancet, 386(9996), 896-912.
- Khandelwal, S., & Sharma, S. (2018). Astrocyte activation and neurodegeneration. Brain Research Bulletin, 137, 22-30.
- Kim, Y. S., & Joh, T. H. (2006). Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Experimental & Molecular Medicine, 38(4), 333-347.
- Kumar, A., & Gupta, A. (2020). Role of neuroinflammation in neurodegenerative diseases. Indian Journal of Neurosciences, 6(2), 76-83.
- Lakatos, A., et al. (2000). Oligodendroglia, microglia, and cytokine interactions in CNS injury. Glia, 30(2), 211-216.
- Li, G., & Yang, H. (2016). Astrocyte dysfunction in neurodegenerative diseases. Journal of Neuroscience Research, 94(9), 809-818.
- Perry, V. H., & Holmes, C. (2014). Microglial priming in neurodegenerative disease. Nature Reviews Neurology, 10(4), 217-224.
- Prinz, M., & Priller, J. (2014). Microglia and brain macrophages in the molecular age: From origin to neuropsychiatric disease. Nature Reviews Neuroscience, 15(5), 300-312.
- Ransohoff, R. M., & Brown, M. A. (2012). Innate immunity in the central nervous system. Journal of Clinical Investigation, 122(4), 1164-1171.
- Roy, A., & Mukherjee, S. (2018). Neuroinflammation and Alzheimer's disease. Indian Journal of Medical Research, 148(5), 530-541.
- Singh, A., & Patro, N. (2020). Glial cells and neuroinflammation in Parkinson's disease. Journal of Clinical Neuroscience, 73, 1-7.
- Sofroniew, M. V., & Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta Neuropathologica, 119(1), 7-35.
- Stoll, G., & Jander, S. (1999). The role of microglia and macrophages in the pathophysiology of the CNS. Progress in Neurobiology, 58(3), 233-247.
- Verma, A., & Singh, A. (2019). The impact of neuroinflammation on neurodegenerative diseases. Journal of Neuroscience Research, 97(1), 1-14.
- Yong, V. W., & Rivest, S. (2009). Taking advantage of the systemic immune system to cure brain diseases. Neuron, 64(1), 55-60.
- Zhang, J., & Liu, Q. (2015). Microglial activation and neuroinflammation in Alzheimer's disease. Journal of Neuroimmune Pharmacology, 10(4), 651-660.